William A. Heyburn - 31 Oct 2025 Form 4 Insider Report for Strata Critical Medical, Inc. (BLDE)

Role
Co-CEO and CFO, Director
Signature
/s/ Melissa M. Tomkiel, as attorney-in-fact for William A. Heyburn
Issuer symbol
BLDE
Transactions as of
31 Oct 2025
Net transactions value
-$503,669
Form type
4
Filing time
05 Nov 2025, 16:52:08 UTC
Previous filing
12 Sep 2025
Next filing
10 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Heyburn William A. Co-CEO and CFO, Director C/O STRATA CRITICAL MEDICAL, INC., 31 HUDSON YARDS, 14TH FLOOR, NEW YORK /s/ Melissa M. Tomkiel, as attorney-in-fact for William A. Heyburn 05 Nov 2025 0001859732

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRTA Class A common stock, $0.0001 par value per share Award $0 +181,072 +14% $0.000000 1,486,569 31 Oct 2025 Direct F1
transaction SRTA Class A common stock, $0.0001 par value per share Tax liability $503,669 -100,133 -6.7% $5.03 1,386,436 03 Nov 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 8, 2024.
F2 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.